Sponsored By

Medtech's Big Market Movers (Nanobiotix)


April 6, 2015

1 Min Read
Medtech's Big Market Movers (Nanobiotix)

Nanobiotix wants to transform therapy using its NanoXray technology portfolio. When certain nanoparticles are directly injected into cancerous tissue and radiotherapy is applied, these particles have the ability to absorb x-rays and increase the amount of radiation to destroy diseased cells. Surrounding healthy tissue do not get increased radiation doses. 

Last year, the French company's share price jumped 217%, to 16.72 euros ($18.38) from 5.27 euros ($6.85) at the end of 2013. As a result, the company added $221 million to its market cap.


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like